Search results for

Lutnick said last year that he cut ties with Epstein, his former neighbor, in 2005. But the Epstein files indicate that the two kept in contact, including for a 2012 lunch on Epstein's private island.

Israeli officials have accused international groups, including the United Nations, of ignoring what it describes as evidence of rape and sexual violence by Hamas fighters during the Oct. 7 attacks.

NPR's Scott Simon speaks with author Benjamín Labatut about his new novel, "The Maniac," a fictionalized account of a pioneer in the field of artificial intelligence.

The Supreme Court will decide whether a U.S. warrant can compel Microsoft to turn over a user's emails stored in Ireland. It also seems to want Congress to fix the dilemma.

The Atlantic writer Clint Smith explored how sites across the U.S. grapple with their relationship to chattel slavery, then visited Holocaust memorials in Germany. Here are three of his takeaways.

As special correspondent and guest host of NPR's news programs, Melissa Block brings her signature combination of warmth and incisive reporting. Her work over the decades has earned her journalism's highest honors, and has made her one of NPR's most familiar and beloved voices.

Rodney Carmichael is NPR Music's hip-hop staff writer. An Atlanta-bred cultural critic, he helped document the city's rise as rap's reigning capital for a decade while serving on staff as music editor, culture writer and senior writer for the defunct alt-weekly Creative Loafing.

Even though the billionaire is no longer leading the Department of Government Efficiency effort, many key staffers — and DOGE ideas — are now more permanently embedded in the federal government.

During lockdown, gyms were out of the question. But some people felt more comfortable exercising at home, and companies hope to keep attracting new users by making VR apps more addictive and fun.

Voters in seven states pick candidates for the midterms. Russia and Turkey weigh a deal that could impact global food supplies. And a fourth COVID-19 vaccine nears US approval.